Zum Hauptinhalt springen

Hepatitiden

11. September 2017 | Hepatitiden

Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes

Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes Mazhnaya, Alyona et al. International Journal of Drug Policy , Volume 47 , 1…

11. September 2017 | Hepatitiden

HBV recurrence after HCV clearance on DAAs: Sometimes They Come Back

HBV recurrence after HCV clearance on DAAs: Sometimes They Come Back Calvaruso, Vincenza et al. Journal of Hepatology , Volume 0 , Issue 0 , doi.org/10.1016/j.jhep.2017.08.017 http://www.journal-of-hepatology.eu/article/S0168-8278(17)32256-0/full…

10. September 2017 | Hepatitiden

Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience.

Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience. Milazzo L, Magni C, Niero F, Schiavini M, Lai A, Cento V, Binda F, Antinori S, Sollima S. Eur J G…

04. September 2017 | Hepatitiden

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial Forns, Xavier et al. The Lancet Infectious Dis…

04. September 2017 | Hepatitiden

Preisübersicht verfügbare HCV-DAA (Rabattverträge nicht berücksichtigt)

(hepatitisandmore.de, Stand 23. August 2017) http://www.hepatitisandmore.de/hepatitis_c/medikamente/preis_uebersicht.shtml

04. September 2017 | Hepatitiden

Pharmakotherapie der chronischen Hepatitis-C-Virus-Infektion und Krebsrisiko

Pharmakotherapie der chronischen Hepatitis-C-Virus-Infektion und Krebsrisiko Einfluss direkt antiviral wirksamer Medikamente auf die Entstehung und Rekurrenz des hepatozellulären Karzinoms Drug treatment for chronic hepatitis C infection and…

04. September 2017 | Hepatitiden

Hepatitis B and C in Eastern Europe and Central Asia: an epidemic and a response

Hepatitis B and C in Eastern Europe and Central Asia: an epidemic and a response Alliance for Public Health, 08.08.2017, Report in Russian. http://fileserver.idpc.net/library/Hepatitis-B-and-C-in-Eastern-Europe-and-Central-Asia-an-epidemic-and-a-r…

Weitere
akutelle Informationen
zu den Themengebieten